Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours.
Front Immunol. 2023 Feb 22;13:982082. doi: 10.3389/fimmu.2022.982082. eCollection 2022.
Front Immunol. 2023.
PMID: 36923728
Free PMC article.
Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33.
Saranchova I, Han J, Huang H, Fenninger F, Choi KB, Munro L, Pfeifer C, Welch I, Wyatt AW, Fazli L, Gleave ME, Jefferies WA.
Saranchova I, et al.
Sci Rep. 2016 Sep 13;6:30555. doi: 10.1038/srep30555.
Sci Rep. 2016.
PMID: 27619158
Free PMC article.
Item in Clipboard
Type 2 Innate Lymphocytes Actuate Immunity Against Tumours and Limit Cancer Metastasis.
Saranchova I, Han J, Zaman R, Arora H, Huang H, Fenninger F, Choi KB, Munro L, Pfeifer CG, Welch I, Takei F, Jefferies WA.
Saranchova I, et al.
Sci Rep. 2018 Feb 13;8(1):2924. doi: 10.1038/s41598-018-20608-6.
Sci Rep. 2018.
PMID: 29440650
Free PMC article.
Item in Clipboard
Serum free culture for the expansion and study of type 2 innate lymphoid cells.
de Lucía Finkel P, Sherwood C, Saranchova I, Xia W, Munro L, Pfeifer CG, Piret JM, Jefferies WA.
de Lucía Finkel P, et al. Among authors: saranchova i.
Sci Rep. 2021 Jun 10;11(1):12233. doi: 10.1038/s41598-021-91500-z.
Sci Rep. 2021.
PMID: 34112824
Free PMC article.
Item in Clipboard
A novel cell-based screen identifies chemical entities that reverse the immune-escape phenotype of metastatic tumours.
Nohara LL, Ellis SLS, Dreier C, Dada S, Saranchova I, Bok Choi K, Munro L, Al Haddad E, Pfeifer CG, Coyle KM, Morrice JR, Shim DJS, Ahn P, De Voogd N, Williams DE, Cheng P, Garrovillas E, Andersen RJ, Jefferies WA.
Nohara LL, et al. Among authors: saranchova i.
Front Pharmacol. 2023 May 15;14:1119607. doi: 10.3389/fphar.2023.1119607. eCollection 2023.
Front Pharmacol. 2023.
PMID: 37256225
Free PMC article.
Item in Clipboard
A novel type-2 innate lymphoid cell-based immunotherapy for cancer.
Saranchova I, Xia CW, Besoiu S, Finkel PL, Ellis SLS, Kari S, Munro L, Pfeifer CG, Fazli L, Gleave ME, Jefferies WA.
Saranchova I, et al.
Front Immunol. 2024 Mar 7;15:1317522. doi: 10.3389/fimmu.2024.1317522. eCollection 2024.
Front Immunol. 2024.
PMID: 38524132
Free PMC article.
Item in Clipboard
A diversity of novel type-2 innate lymphoid cell subpopulations revealed during tumour expansion.
Xia CW, Saranchova I, Finkel PL, Besoiu S, Munro L, Pfeifer CG, Haegert A, Lin YY, Le Bihan S, Collins C, Jefferies WA.
Xia CW, et al. Among authors: saranchova i.
Commun Biol. 2024 Jan 3;7(1):12. doi: 10.1038/s42003-023-05536-0.
Commun Biol. 2024.
PMID: 38172434
Free PMC article.
Item in Clipboard
Curcuphenol possesses an unusual histone deacetylase enhancing activity that counters immune escape in metastatic tumours.
Ellis SLS, Dada S, Nohara LL, Saranchova I, Munro L, Pfeifer CG, Eyford BA, Morova T, Williams DE, Cheng P, Lack NA, Andersen RJ, Jefferies WA.
Ellis SLS, et al. Among authors: saranchova i.
Front Pharmacol. 2023 Aug 10;14:1119620. doi: 10.3389/fphar.2023.1119620. eCollection 2023.
Front Pharmacol. 2023.
PMID: 37637416
Free PMC article.
Item in Clipboard
Cite
Cite